Medicus Bergen AS
- Address
- lock Available on a paid plan
Female Urogenital Diseases and Pregnancy Complications
At Medicus Bergen AS, researchers are concentrating on female urogenital health and pregnancy challenges, aiming to improve outcomes for women facing reproductive difficulties. Current studies assess a novel compound together with follitropin delta during controlled ovarian stimulation to boost the effectiveness of assisted reproduction.
- Effect of FE 999302 on ovarian response during assisted reproductive cycles
- Optimal timing of FE 999302 administration in controlled ovarian stimulation
The dedicated team at the site seeks to advance infertility treatments and support patients undergoing ART procedures, contributing valuable insights to women's reproductive health.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ferring Pharmaceuticals A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medicus Bergen AS
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Exploratory Study on the Effects of FE 999302 During Controlled Ovarian Stimulation with Follitropin Delta in Women Undergoing ART for Infertility | Ferring Pharmaceuticals A/S | Phase I | Not Recruiting | Jul 2024 | Sep 2025 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.